Skip to main content
Device Global Header

Subscribe
or Renew

Advanced Search

Editor’s Note: This letter was published on June 4, 2020, at NEJM.org.

CorrespondenceRetraction

Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.

To the Editor:

Because all the authors were not granted access to the raw data and the raw data could not be made available to a third-party auditor, we are unable to validate the primary data sources underlying our article, “Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.”1 We therefore request that the article be retracted. We apologize to the editors and to readers of the Journal for the difficulties that this has caused.

Mandeep R. Mehra, M.D.
Brigham and Women’s Hospital Heart and Vascular Center, Boston, MA

Sapan S. Desai, M.D., Ph.D.
Surgisphere, Chicago, IL

SreyRam Kuy, M.D., M.H.S.
Baylor College of Medicine, Houston, TX

Timothy D. Henry, M.D.
Christ Hospital, Cincinnati, OH

Amit N. Patel, M.D.
University of Utah, Salt Lake City, UT

Disclosure forms provided by the authors are available with the full text of this letter at NEJM.org.

This letter was published on June 4, 2020, at NEJM.org.

  1. 1. Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med 2020;382:e102-e102.

Supplementary Material

Citing Articles (235)